(c) 2024 PillSync.com

Amlodipine 5 MG Benazepril hydrochloride 40 MG Oral Capsule

1 INDICATIONS AND USAGE Amlodipine and benazepril hydrochloride capsules are a combination capsule of amlodipine, a dihydropyridine calcium channel blocker (DHP CCB) and benazepril, an angiotensin converting enzyme (ACE) inhibitor. Amlodipine and benazepril hydrochloride capsules are indicated for the treatment of hypertension in patients not adequately controlled on monotherapy with either agent. ( 1 ) 1.1 Hypertension Amlodipine and benazepril hydrochloride capsules are indicated for the treatment of hypertension in patients not adequately controlled on monotherapy with either agent.

Mylan Pharmaceuticals Inc.


3 years ago CAPSULE BLUE Mylan 6899 Amlodipine 5 MG  Benazepril hydrochloride 40 MG Oral Capsule

CAPSULE BLUE Mylan 6899

16 HOW SUPPLIED/STORAGE AND HANDLING Amlodipine and Benazepril Hydrochloride capsules, USP are available containing amlodipine besylate, USP equivalent to 2.5 mg, 5 mg or 10 mg of amlodipine, with 10 mg, 20 mg or 40 mg of benazepril hydrochloride, USP providing for the following available combinations: 2.5 mg/10 mg, 5 mg/10 mg, 5 mg/20 mg, 10 mg/20 mg, 5 mg/40 mg or 10 mg/40 mg. The 2.5 mg/10 mg capsule is a hard-shell gelatin capsule with a Lavender opaque cap and a Lavender opaque body axially printed with MYLAN over 6895 in black ink on both the cap and the body. The capsule is filled with one blue, round tablet with no markings and one white, film-coated, round tablet with no markings. They are available as follows: NDC 0378-6895-01 bottles of 100 capsules The 5 mg/10 mg capsule is a hard-shell gelatin capsule with a blue opaque cap and a blue opaque body axially printed with MYLAN over 6896 in black ink on both the cap and the body. The capsule is filled with one blue, round tablet with no markings and one white, film-coated, round tablet with no markings. They are available as follows: NDC 0378-6896-01 bottles of 100 capsules The 5 mg/20 mg capsule is a hard-shell gelatin capsule with a Lavender opaque cap and a peach opaque body axially printed with MYLAN over 6897 in black ink on both the cap and the body. The capsule is filled with one blue, round tablet with no markings and one white, film-coated, round tablet with no markings. They are available as follows: NDC 0378-6897-01 bottles of 100 capsules The 10 mg/20 mg capsule is a hard-shell gelatin capsule with a blue opaque cap and a peach opaque body axially printed with MYLAN over 6898 in black ink on both the cap and the body. The capsule is filled with one blue, round tablet with no markings and one white, film-coated, round tablet with no markings. They are available as follows: NDC 0378-6898-01 bottles of 100 capsules The 5 mg/40 mg capsule is a hard-shell gelatin capsule with a blue opaque cap and a light pink opaque body axially printed with MYLAN over 6899 in black ink on both the cap and the body. The capsule is filled with one blue, round tablet with no markings and one beige, film-coated, round tablet with no markings. They are available as follows: NDC 0378-6899-01 bottles of 100 capsules The 10 mg/40 mg capsule is a hard-shell gelatin capsule with a Lavender opaque cap and a light pink opaque body axially printed with MYLAN over 6900 in black ink on both the cap and body. The capsule is filled with one blue, round tablet with no markings and one beige, film-coated, round tablet with no markings. They are available as follows: NDC 0378-6900-01 bottles of 100 capsules Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from moisture. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. PHARMACIST: Dispense a Patient Information Leaflet with each prescription.


More pills like CAPSULE Mylan 6899












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site